Xu, C., Wang, S., Meng, D., Wang, M., Yan, R., & Dai, Y. Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways. BMC.
Chicago Style (17th ed.) CitationXu, Chengan, Shouhao Wang, Di Meng, Mingshan Wang, Rong Yan, and Yining Dai. Neuregulin1 Ameliorates Metabolic Dysfunction-associated Fatty Liver Disease via the ERK/SIRT1 Signaling Pathways. BMC.
MLA (9th ed.) CitationXu, Chengan, et al. Neuregulin1 Ameliorates Metabolic Dysfunction-associated Fatty Liver Disease via the ERK/SIRT1 Signaling Pathways. BMC.
Warning: These citations may not always be 100% accurate.